The CEO of Pfizer Is Now the World’s Highest Paid Pharma boss

While Moderna CEO became a multi billionaire during the covid hysteria era.

By Jordan Schachtel
Global Research, August 26, 2023
The Dossier
Theme:

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Click the share button above to email/forward this article to your friends and colleagues. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

*** 

Albert Bourla, the notorious snake oil salesman and horse doctor who serves as the CEO of Pfizer, is now the highest paid executive in the entire Pharma industry.

In Vivo has published the total compensation package for Bourla, which last year reached an astronomical $33 million dollars. He has earned just short of $100 million in salary since 2019. On top of that, Bourla has earned tens of millions through the sale of Pfizer stock. At the end of last year, he sold 222,328 shares of Pfizer stock, cashing out over $6 million. He retains about a quarter million shares in the company.

Credit: In Vivo

Under his “leadership” while serving as CEO of Pfizer since 2019, Bourla worked with both the Trump Administration and Biden Administration (along with countless additional nations) to loot billions of dollars from the treasuries of dozens of nations, striking deals in which Pfizer provided a “free vaccine” that redirected all of their costs on to taxpayers instead of Pfizer. On top of that, all of the profits generated from the shots went directly to Pfizer, allowing for the Pharma giant to publish record profits year after year.

Almost all of Pfizer’s profits since the beginning of the covid hysteria era have come from its mRNA shot and horse pills that are branded Paxlovid. Without Covid-19, Pfizer would not have made any net income since 2019.

In exchange for the billions of dollars in taxpayer funds, Pfizer was supposed to provide an immunizing and effective agent that worked to stop the Wuhan sniffles. Pfizer succeeded in bamboozling the masses by committing statistical malpractice and outright scamming. In further hyping the Pfizer shots, Bourla often engaged in fraudulent marketing practices, routinely falsely claiming the Pfizer mRNA shot was akin to a cure to the coronavirus.

Not only did their “vaccine” fail to achieve any upside whatsoever or any demonstrated capability to stop the sniffles, it has shown to display an unprecedented side effect portfolio.

Sadly, Bourla is far from the only Pharma exec to make tons of money through the sale of snake oil products.

Stephane Bancel, the CEO of Moderna, turned into a billionaire during the Covid-19 era, thanks to his large equity stake in the company.

Via Forbes

Bancel also rakes in almost $20 million a year in compensation, per In Vivo.

*

Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Featured image is from Kanekoa the Great
Articles by: Jordan Schachtel

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]